Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
licensing
Biotech
Elevar offers $500M biobucks for Relay's rare cancer asset
Relay has signed a deal worth up to $500 million biobucks that gives Elevar rights to an oral small molecule in solid tumors.
Gabrielle Masson
Dec 3, 2024 3:04pm
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
Bayer pharma BD chief says group overhaul not slowing deals
Aug 15, 2024 2:30pm
Gilead pays J&J $320M to exit licensing deal for seladelpar
Aug 9, 2024 10:30am
AI-focused Formation bags $372M series D to license more drugs
Jun 26, 2024 10:05am
Astellas bets more than $800M on Kelonia's delivery tech
Feb 15, 2024 6:30pm
